A Markov model for HIV disease progression including the effect of HIV diagnosis and treatment: application to AIDS prediction in England and Wales.
Back-calculation is a widely used method to estimate HIV incidence rates, and is commonly based on times of AIDS diagnosis. Following up earlier work, we extend this method to also incorporate knowledge of times of HIV diagnosis (first positive test). This is achieved through the use of a Markov model which describes the progress of an HIV infected person through various stages, and which allows causal connections between events to be explicitly modelled. Estimation is based on maximum likelihood, the likelihood being calculated within a discretized version of the Markov model. The effect of sampling uncertainty and model uncertainty (sensitivity) is evaluated simultaneously by means of a combined bootstrap and simulation procedure. At each replication we resample both the data and the model (from a set of possible models described by randomizing one or more parameters). For instance, uncertain knowledge about the incubation distribution affects the estimates of some parameters, but not others. The Markov approach is applied to the prediction of AIDS incidence for homosexuals in England and Wales up to the year 2000.
Aalen
O O
OO
Section of Medical Statistics, University of Oslo, Norway.
Farewell
V T
VT
De Angelis
D
D
Day
N E
NE
Gill
O N
ON
D015492:AIDS Serodiagnosis / Q000706:statistics & numerical data; D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D019380:Anti-HIV Agents / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D018450:Disease Progression; D004739:England / Q000453:epidemiology; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D016013:Likelihood Functions; D008390:Markov Chains; D015233:Models, Statistical; D014852:Wales / Q000453:epidemiology
D019380:Anti-HIV Agents